Noradrenaline Sintetica (Noradrenaline Tartrate)

Noradrenaline Tartrate, the active ingredient in Noradrenaline Sintetica, is a catecholamine presented as an injectable solution for intravenous use. It acts as a potent vasopressor to raise blood pressure in patients experiencing severe hypotension, septic shock, or cardiac arrest.

GNH USA supplies Noradrenaline Sintetica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Our quality‑assured manufacturing follows EU pharmacopeial standards, and we provide regulatory support for import and registration. We ensure timely delivery and maintain product integrity throughout the supply chain.

Noradrenaline Sintetica is a catecholamine vasopressor used in critical care to support circulatory function.

- Hypotension: rapidly restores arterial pressure in patients with acute low blood pressure, helping to maintain organ perfusion. - Septic shock: improves hemodynamic stability by counteracting profound vasodilation, supporting blood pressure and tissue oxygen delivery. - Cardiac arrest: provides temporary circulatory support during advanced cardiac life support, facilitating perfusion until return of spontaneous circulation.

Noradrenaline Sintetica may cause a range of adverse reactions that clinicians monitor during therapy.

Common Side Effects: - Tachycardia - Headache - Nausea - Arrhythmia - Peripheral ischemia

Serious or Rare Side Effects: - Myocardial ischemia - Severe hypertension - Lactate accumulation - Tissue necrosis at the infusion site

When using Noradrenaline Sintetica, careful clinical monitoring and appropriate handling are essential.

- Dose titration: adjust infusion rate based on blood pressure response. - Cardiac monitoring: continuous ECG monitoring is required. - Extravasation risk: avoid infiltration; monitor IV site closely. - Renal impairment: use with caution and monitor renal function. - Concomitant MAO inhibitors: avoid due to risk of hypertensive crisis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline Sintetica can interact with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - MAO inhibitors: may cause severe hypertension. - Beta‑blockers: can blunt the desired vasopressor effect. - Tricyclic antidepressants: increase risk of arrhythmias.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance vasoconstrictive response. - Diuretics: may potentiate hypotensive rebound when therapy is withdrawn. - Inhaled anesthetics: may require dose adjustments of Noradrenaline.